💥Join UPSC 2027,2028 Mentorship (July Batch) + XFactor Notes & Microthemes PDF
Talk to Mentor

Civilsdaily

Login

Subject: Science and Technology

  • WorldCoin: Building a Global Digital Network with Biometric Identity

    worldcoin
    PC: The Hindu

    Central Idea

    • OpenAI CEO Sam Altman recently reintroduced Worldcoin, a project that was previously overshadowed by the popularity of ChatGPT.

    What is WorldCoin?

    • The Worldcoin venture involves a unique model where individuals have their eyes scanned to establish their human uniqueness.
    • In return for the eye scan, participants receive cryptocurrency and a World ID, forming the basis of the project.
    • Worldcoin’s aim is to create the “world’s largest identity and financial public network,” accessible to people globally.

    How does it works?

    • Orb Operators: Worldcoin relies on volunteers called “Orb operators” who use a device called “Orb” to scan people’s iris patterns and collect their biometric data.
    • World ID: Participants receive a World ID through the World app after getting their irises scanned. This unique ID allows them to claim Worldcoin cryptocurrency and conduct transactions.
    • Proof of Personhood: Scanning irises ensures that people cannot sign up multiple times to receive more crypto rewards.
    • Cryptocurrency and Transactions: Users can collect WLD at regular intervals or use it for transactions, similar to a standard digital currency.

    WLD Cryptocurrency and Compliance

    • WLD Token: WLD is a cryptocurrency based on the Ethereum blockchain and can be bought, sold, or traded on major exchanges.
    • Regulatory Compliance: Worldcoin ensures compliance with Europe’s GDPR and uses zero-knowledge proofs (ZKPs) to maintain user privacy. User data is encrypted and not sold, though it may be shared with necessary third parties.

    Various risks

    • Price Volatility: As with most cryptocurrencies, the price of WLD is subject to fluctuations. Its value can rise or fall, and users should be cautious about investing in lesser-known digital currencies.
    • Security Risks: Users must be wary of potential scams or hacks related to cryptocurrency investments.

    Criticism and Controversies

    • Privacy Concerns: Worldcoin faced criticism over privacy concerns about the use of biometrics for verification.
    • Scanning in Emerging Economies: Reports indicated that Worldcoin scanned underprivileged people’s irises in emerging economies during the COVID-19 pandemic, raising ethical questions about informed consent and rewards for scans.

    Worldcoin in India

    • Orb Operators in India: Worldcoin has deployed Orb operators in various locations, particularly in Delhi, Noida, and Bangalore, where people’s irises are scanned to join the network.

    Conclusion

    • Worldcoin’s vision of a global digital network with biometric identity and cryptocurrency rewards is both promising and controversial.
    • While it aims to foster financial inclusion and provide digital opportunities, it must address privacy and ethical concerns to gain wider acceptance and trust among users worldwide.

  • Potential of Cell-Free DNA (cfDNA) in Disease Research

    DNA

    Central Idea

    • Researchers worldwide are increasingly using Cell-free DNA (cfDNA) as a valuable tool to better comprehend human diseases, improve diagnosis, monitoring, and prognosis.

    What is Cell-free DNA?

    • CfDNA refers to small fragments of nucleic acids that are released from cells and found outside the cell in body fluids.
    • Its discovery dates back to the late 1940s when it was first observed in the blood of pregnant women.
    • cfDNA can be generated and released from cells in various situations, such as cell death and other physiological processes.
    • The release of cfDNA is associated with several disease processes, including autoimmune diseases like systemic lupus erythematosus.

    How is it different from normal DNA?

    Cell-free DNA

    Normal DNA
    Found in the bloodstream and other bodily fluids Found within the cell nucleus or mitochondria
    Released from dying or dead cells into the circulation Remains within the cell’s nucleus or mitochondria
    Exists in a fragmented form Exists as an intact double-stranded helix
    Can be isolated and analyzed from blood samples Requires cell extraction and purification for analysis
    Provides valuable genetic information for personalized medicine Forms the basis of genetic inheritance and traits
    Valuable in infectious disease diagnosis and monitoring Not used for infectious disease diagnosis
    Used in forensics for DNA profiling and crime investigations Not typically used in forensics

     

    Applications of CfDNA

    Non-Invasive Prenatal Testing (NIPT) Detect genetic abnormalities in foetuses

    Screening for Down syndrome, Edwards syndrome, and Patau syndrome
    Cancer Screening and Monitoring Identify genetic mutations in tumour cells

    Determine cancer type

    Monitor treatment response and disease progression
    Transplant Rejection Monitoring Monitor immune response after organ transplantation

    Early detection of organ rejection
    Infectious Disease Diagnosis Identify viruses and bacteria in the bloodstream

    Aid in diagnosing infections and guiding treatment
    Personalized Medicine Provide genetic information for tailored treatment plans

    Enable precision medicine based on individual genetic profile
    Tracking Tumour Mutations Monitor drug-resistant mutations in cancer patients for treatment adjustments

     

    Recent Advances in Therapeutics

    • GEMINI Test: Researchers at Johns Hopkins Kimmel Cancer Centre developed a new test called ‘GEMINI’ that uses cfDNA for early cancer detection. By analyzing genetic mutations and using machine learning, they achieved over 90% accuracy in detecting lung cancer, even in early-stage cases.
    • Potential Impact: Early detection of cancers using cfDNA could significantly improve patient outcomes and survival rates.

  • BPaL Trial yields 85% TB Cure Rate

    tb

    Central Idea

    • The interim results of a randomized phase-3/4 trial conducted in India to evaluate the safety and effectiveness of BPaL Regimen, an all-oral, short-course treatment are promising.
    • BPaL is administered for individuals with pre-XDR TB or treatment-intolerant/non-responsive MDR pulmonary TB

    What is BPaL?

    • The trial uses only three drugs—Bedaquiline, Pretomanid, and Linezolid (BPaL).
    • The treatment duration is only 26 weeks, contrasting with the conventional 18-month treatment involving eight to nine tablets per day.

    Trial Outcomes

    • It offered a significantly reduced number of tablets per day, resulting in better treatment adherence and improved outcomes.
    • Approximately 70% of the trial participants have completed the 26-week treatment, with a cure rate exceeding 85%.
    • In comparison, the cure rate for conventional treatment for DR-TB is 60-65% even with strict adherence.

    Treatment Superiority

    • Advanced TB Cases: The trial participants had advanced TB affecting both lungs, yet the cure rate was above 85%, demonstrating the superiority of the BPaL short-course therapy.
    • Importance of Early Diagnosis: Early diagnosis and initiation of treatment with the three-drug regimen can lead to even better outcomes for patients with pre-XDR TB.

    Issues with the treatment

    • Three to four trial participants experienced serious adverse effects, but these were either managed or occurred too late in the disease’s progression to be helped.
    • Some cases of mild adverse effects caused by linezolid included a drop in haemoglobin and platelet counts, as well as neuropathy (tingling sensation and numbness in the legs).

    TB Menace in India

    • Total TB Cases: In 2021, there were approximately 21.3 lakh (2.13 million) reported TB cases in India.
    • Incidence Rate: The incidence rate of TB in India in 2021 was 210 cases per lakh population.
    • Drug-Resistant TB: The number of drug-resistant TB cases in India declined from around 1.49 lakh in 2015 to 1.19 lakh in 2021.
    • Government Initiatives: To combat TB, India has set the target of eliminating the disease by 2025, and various initiatives have been implemented, including active case finding, screening, and improved access to diagnostic tests and treatment.

    Back2Basics:

    XDR TB (Extensively Drug-Resistant TB)

    Treatment-Intolerant/Non-Responsive MDR Pulmonary TB
    Resistant to most effective first-line and some second-line TB drugs. Patient cannot tolerate prescribed medications or infection does not respond to treatment.
    More dangerous and difficult to treat than MDR TB. Requires exploration of alternative treatment regimens.
    Limited treatment options, higher mortality, and increased transmission risk. Adjustments in drug combinations or dosages may be needed.
    Spreads rapidly, posing a serious public health threat. Crucial to prevent development of extensively drug-resistant strains.
    Requires preventive measures and early diagnosis. Identifying reasons for treatment intolerance and providing support.

     

  • [pib] Hematene Nanoflakes

    hematene

    Central Idea

    • Researchers have made a groundbreaking discovery of nanoflakes of a material known as hematene, extracted from iron ore.
    • These nanoflakes have demonstrated exceptional capabilities in withstanding and shielding against high laser intensities.

    What is Hematene?

    • Hematene is a novel 2D material that has been derived from hematite (common iron ore).
    • It is a thin, single-layer material with unique properties that make it promising for various applications, especially in the field of optics.
    • Hematene nanoflakes have demonstrated exceptional capabilities in withstanding and shielding against high laser intensities, making them valuable for optical limiting applications.
    • The material’s stability and potential for futuristic technologies have garnered significant interest from researchers and scientists.

    How is it made?

    • Hematene is derived from naturally occurring hematite, the mineral form of iron oxide, through a process involving sonication, centrifugation, and vacuum-assisted filtration.
    • With a thickness of just 3 atoms, it exhibits improved photocatalysis efficiency.
    • Being ferromagnetic, like common magnets, it possesses magnetic properties.
    • Notably, it has the exceptional ability to withstand and provide shielding against high laser intensities.

    Applications of Hematene Nanoflakes

    • Optical Limiting: Hematene nanoflakes have demonstrated exceptional optical limiting capabilities, making them valuable in protecting sensitive optical equipment, such as sensors, detectors, and other optical devices, from high laser intensities.
    • Photodetectors: Hematene’s properties make it suitable for developing high-performance photodetectors, which are used to detect and convert light signals into electrical signals. This application has potential in telecommunications, imaging, and optical communications.
    • Energy Storage: Hematene can be explored for applications in energy storage devices, such as batteries and super-capacitors, due to its unique electronic and electrochemical properties.
    • Optoelectronics: The material’s properties make it suitable for optoelectronic devices, which involve the interaction of light and electricity, including light-emitting diodes (LEDs) and photovoltaic cells.
    • Photothermal Therapy: Hematene’s ability to withstand and shield against high laser intensities may find applications in photothermal therapy, a medical technique that uses light to treat diseases like cancer.
    • Environmental Applications: Hematene’s stability and potential for use in various environments may make it valuable in environmental applications, such as water purification and pollution control.
    • Sensors: The material’s unique properties may be utilized in developing high-performance sensors for various applications, including gas sensing and environmental monitoring.
    • Catalysts: Hematene’s surface characteristics and electronic properties could be explored for catalytic applications, promoting chemical reactions in various industrial processes.

  • Semicon India 2023: How government’s support and will built the semiconductor industry

    What’s the news?

    • The second edition of Semicon India, hosted by the India Semiconductor Mission (ISM), comes at a pivotal moment for the global semiconductor industry.

    Central idea

    • As technology advances rapidly and geopolitical landscapes shift, India is determined to foster a thriving domestic ecosystem to achieve self-sufficiency and emerge as a key player in the global semiconductor value chain.

    What is Semicon India?

    • Semicon India is the annual conference organized by the India Semiconductor Mission (ISM).
    • The primary objective of Semicon India is to promote the growth and development of the semiconductor industry in India.
    • It provides an opportunity for the country to demonstrate its capabilities in semiconductor design and manufacturing while fostering networking and knowledge exchange among participants.

    What are Semiconductors?

    • Semiconductors are a class of materials that have unique electrical properties, making them intermediate in conductivity between conductors and insulators. They are a vital component in the manufacturing of various electronic devices and play a crucial role in modern technology.

    India’s journey in the semiconductor industry

    • Early Efforts: India’s initial forays into the semiconductor sector began with public sector undertakings like Bharat Electronics Ltd. (BEL) and some other labs and institutions attempting to establish a presence in the industry. However, despite promising starts, India faced difficulties in achieving the volume and technology needed for competitiveness.
    • Missed Opportunities: Over the years, India encountered several missed opportunities that hindered its progress in the semiconductor field. One notable example is missing out on the Fairchild Semiconductor fab in the 1960s. Additionally, regulatory and bureaucratic hurdles prevented global semiconductor companies from showing interest in investing in India’s semiconductor manufacturing.
    • Setbacks and Challenges: India’s major VLSI fabrication plant at the Semiconductor Complex Limited (SCL) in Chandigarh began production before Taiwan’s entry into semiconductor manufacturing. Unfortunately, a massive fire in 1989 led to the closure of the plant for many years, hampering India’s progress in the industry.
    • Government Recognition: The Indian government came to recognize the economic and geopolitical significance of the semiconductor industry. Realizing the importance of achieving semiconductor self-sufficiency, the government launched the India Semiconductor Mission (ISM) to bolster the domestic ecosystem and position India as a key player in the global semiconductor value chain.

    The birth of the India Semiconductor Mission (ISM)

    • The India Semiconductor Mission (ISM) was launched as a significant initiative by the Indian government to bolster the semiconductor industry in the country.
    • It came into existence with a clear vision of nurturing a thriving domestic semiconductor ecosystem to achieve self-sufficiency and elevate India’s position as a key player in the global semiconductor value chain.
    • The mission’s proactive approach, combined with concrete policy interventions and political will, marks a new chapter in India’s journey in the semiconductor sector.

    The significance of domestic semiconductor manufacturing for India

    • Economic Growth: By manufacturing semiconductors domestically, India can reduce its dependence on imports, save foreign exchange, and contribute to economic growth by generating revenue and employment opportunities.
    • Technological Advancement: Domestic semiconductor manufacturing enhances India’s capabilities in cutting-edge technologies, research, and development. It fosters innovation and facilitates the growth of other technology-driven sectors, including artificial intelligence, the Internet of Things (IoT), 5G, and advanced electronics. This, in turn, can boost India’s competitiveness on the global technology stage.
    • Self-Reliance and Security: Developing a self-reliant semiconductor ecosystem ensures continuity in critical industries and safeguards against global disruptions. It also enhances India’s national security, as semiconductors play a vital role in defense and communication infrastructure.
    • Attracting Investment: A strong semiconductor manufacturing ecosystem attracts both domestic and foreign investments. This leads to the establishment of semiconductor fabrication plants, research centers, and collaborations with global technology companies.
    • Fostering Innovation: A thriving semiconductor industry encourages local innovation and entrepreneurship. It provides opportunities for startups and research institutions to develop innovative semiconductor technologies and solutions, positioning India as a global innovation hub.
    • Digital Sovereignty: In an increasingly interconnected and digitally driven world, possessing domestic semiconductor manufacturing capabilities is vital for digital sovereignty. It allows India to control its critical technology infrastructure and data security, reducing its reliance on foreign technology providers.

    Overwhelming global interest in India as a destination for semiconductor manufacturing

    • Growing Market Potential: India’s large and rapidly growing economy presents a significant market for semiconductor products, attracting global semiconductor companies to establish a presence in the country.
    • Government Support and Vision: The Indian government’s clear vision and commitment to nurturing a thriving domestic semiconductor ecosystem through initiatives like the India Semiconductor Mission (ISM) have instilled confidence among global players.
    • Strategic Importance: Policymakers in India recognize the strategic significance of a robust domestic semiconductor industry for economic growth, safeguarding domestic industries, and ensuring national security.
    • Urgency of Semiconductor Self-Reliance: The global semiconductor shortage and disruptions in supply chains have highlighted the urgency of achieving semiconductor self-reliance, making India an attractive location for semiconductor manufacturing.
    • Fiscal Incentives and Regulatory Support: The Indian government’s unprecedented commitment to fiscal incentives and regulatory support has drawn significant interest from semiconductor companies globally.
    • Skilled Workforce: India’s large pool of skilled engineers and technical talent offers an advantageous workforce for semiconductor companies looking to establish operations in the country.
    • Collaboration with Global Partners: Collaborative agreements with countries like the US and Japan in semiconductor development, research, design, and talent development have enhanced India’s appeal as a semiconductor manufacturing hub.
    • Focus on Sustainability: India’s emphasis on sustainable semiconductor manufacturing through green technologies and resource-efficient practices aligns with the global push for environmentally responsible production.
    • Long-term Support and Progress under ISM: The Indian government’s commitment to long-term support for the semiconductor industry, as demonstrated through initiatives like the Design Linked Incentive (DLI) scheme and modernization of facilities, has garnered attention.
    • Potential for Innovation: India’s thriving innovation ecosystem, including startups and research institutions, presents opportunities for collaborative innovation and technological advancements in the semiconductor industry.

    Conclusion

    • From missed opportunities to a thriving domestic ecosystem, India’s progress in the semiconductor industry is a global case study in building sectors from scratch through appropriate policy interventions and political will. India is now on track to lead the global race in the semiconductor value chain. The ISM reflects India’s determination to achieve semiconductor self-sufficiency and emerge as a major player in the global semiconductor industry.

    Also read:

    Semiconductor Fabrication in India: Learning from Past Attempts and Embracing Alternate Approaches

  • Electron’s Electric Dipole Moment (EDM)

    electron

    Central Idea

    • Researchers from the University of Colorado conducted an experiment to study the electric dipole moment (EDM) of an electron.
    • This EDM measurement could help solve the mystery of why there is more matter than antimatter in the Universe, which goes against the predictions of the Standard Model of particle physics.

    Understanding Electron’s EDM

    • Electric Dipole Moment (EDM): The EDM of an electron is a measure of how its positive and negative electrical charges are distributed. Imagine it like a bar magnet: it shows how asymmetric the charge distribution is within the electron, as if the negative charge (electron) is not perfectly centered with respect to the positive charge (proton) within the particle.
    • Elementary Particles: Electrons are the smallest, fundamental building blocks of matter. Their EDM is an important concept in particle physics because it helps scientists study violations of certain fundamental symmetries, such as time-reversal symmetry and charge-parity symmetry.

    Matter-Antimatter Asymmetry Problem

    • Matter and Antimatter: Matter and antimatter are particles with opposite charges but similar properties. According to the Standard Model, equal amounts of matter and antimatter should have been created during the Big Bang, but this is not what we observe in the Universe.
    • Annihilation: When matter and antimatter come into contact, they annihilate each other, releasing energy. This raises the question of why there is still matter around us, as both should have completely annihilated each other after the Big Bang.

    Measuring the EDM:

    • EDM Measurement: By measuring the EDM of an electron, scientists can determine if the electron’s charge is perfectly centered or slightly off to one side, indicating a separation of charge.
    • Time Symmetry Violation (TSV): If an electron’s EDM is non-zero, it suggests a violation of time symmetry, meaning the behavior of particles is different when time is reversed. This violation could be a clue to explaining the matter-antimatter asymmetry.

    Thesis to this dichotomy: Sakharov’s Conditions

    These are three conditions proposed by physicist Andrei Sakharov to explain why there is more matter than antimatter in the Universe:

    1. Baryon Number Violation: Some processes violate the conservation of baryon number, leading to the creation of more matter than antimatter. Baryons are particles like protons and neutrons.
    2. C-Symmetry and CP-Symmetry Violation: Certain processes treat matter and antimatter differently due to violations of charge conjugation (C-symmetry) and combined charge conjugation with parity (CP-symmetry).
    3. Out-of-Equilibrium Processes: Certain processes happen out of thermal equilibrium, preventing the complete annihilation of particles and resulting in an excess of matter.

    Experiment carried out

    • Complex Experimental Setup: The researchers used advanced techniques involving magnetic fields, lasers, microwaves, and radiofrequency fields to control and measure the EDM of electrons confined inside molecular ions.
    • EDM Bound: The experiment set a limit on the electron’s EDM, indicating that it is about 2.4 times higher than previously measured and roughly 1 billion times larger than predicted by the Standard Model.

    Implications and Future Prospects

    • Searching for New Physics: The measurement of the electron’s EDM opens up the possibility of discovering new physics beyond the Standard Model.
    • Role in Explaining Asymmetry: The knowledge gained from EDM measurements could guide future high-energy particle colliders to produce particles that violate time symmetry, helping us understand why there is more matter than antimatter in the early Universe.

  • Controlled Human Infection Studies (CHIS) in India

    chis

    Central Idea

    • India has taken its first step towards introducing Controlled Human Infection Studies (CHIS), a research model widely used in other countries for vaccine and treatment development.
    • The Indian Council of Medical Research’s (ICMR) Bioethics Unit has prepared a consensus policy statement open for public comment, addressing the need, benefits, and ethical challenges associated with CHIS.

    What is Controlled Human Infection Studies (CHIS)?

    • CHIS also known as human challenge trials, are scientific studies conducted to deliberately expose healthy human volunteers to infectious agents under controlled conditions.
    • The primary objective of these studies is to gain a better understanding of the pathogens’ behavior, human immune response, and to test potential vaccines, treatments, or preventive measures against the infection.

    Key points about Controlled Human Infection Studies (CHIS) include:

    1. Informed Consent: Volunteers participating in CHIS must provide informed consent, fully understanding the potential risks and benefits associated with their participation.
    2. Types of Pathogens: CHIS can be used to study various infectious agents, such as viruses (e.g., influenza, dengue, Zika), bacteria (e.g., cholera, typhoid), and parasites (e.g., malaria).
    3. Vaccine Development: CHIS plays a crucial role in vaccine development by providing controlled environments to assess the efficacy of candidate vaccines and their ability to induce protective immune responses.
    4. Controversy: The use of CHIS has sparked ethical debates about balancing potential risks to participants against potential benefits to public health.

    Ethical Concerns Surrounding CHIS in India

    • Delicate Ethical Balance: CHIS is considered ethically sensitive due to concerns about deliberate harm to participants, fair compensation, third-party risks, and withdrawal from the study, and involving vulnerable participants.
    • Streamlined Ethics Review: ICMR acknowledges the need for a specialized ethics review process with additional oversight and safeguards to protect study participants.
    • Deterrents and Unique Context: Technical, clinical, ethical, and legal challenges deterred India from adopting CHIS earlier, partly influenced by the nation’s unique socio-cultural context.

    Potential Benefits of CHIS in India

    • High Disease Burden: India faces a significant burden of morbidity and mortality from infectious diseases, contributing about 30% of the disease burden in the country.
    • Novel Insights and Efficiency: CHIS offers unique insights into disease pathogenesis and enables accelerated and cost-effective outcomes with smaller sample sizes compared to large clinical trials.
    • Social Value: CHIS can contribute to public health response, healthcare decision-making, policies, economic benefits, improved pandemic preparedness, and community empowerment.

    Encouraging Collaboration and Expertise

    • Complex Nature of CHIS: ICMR highlights the complexity of CHIS and suggests that collaborations between researchers, institutions, organizations, and countries may be necessary to ensure the right expertise is available.
    • Crucial Role in Advancing Scientific Understanding: The ICMR Bioethics Unit’s consensus policy statement aims to address ethical concerns associated with CHIS, acknowledging its potential role in advancing the scientific understanding of infectious diseases and accelerating treatment strategies.

    Public Consultation and Future Directions

    • Open for Public Consultation: The ICMR’s consensus policy statement on CHIS is open for public consultation until August 16 to gather input from stakeholders and experts.
    • Striving for Ethical Research: ICMR emphasizes its commitment to conduct CHIS in India while ensuring ethical principles are upheld and human participants are protected.

    Conclusion

    • The introduction of CHIS in India is a significant step towards advancing medical research and finding cost-effective solutions for infectious diseases.
    • Public consultation and expert collaborations will help shape the future direction of CHIS research in India and contribute to scientific progress and improved healthcare outcomes.

  • Donanemab: A promising drug for Alzheimer’s

    Donanemab

    Central Idea

    • Donanemab, a drug in trials has shown significant potential in slowing cognitive decline in individuals with early Alzheimer’s.

    What is Alzheimer’s Disease?

    • Alzheimer’s disease is a progressive and irreversible neurological disorder.
    • Beta-amyloid, a protein that is crucial for brain function, turns toxic in Alzheimer’s patients, forming clumps that disrupt brain cell connections, leading to cognitive issues like memory loss.
    • These protein deposits disrupt communication between neurons, leading to their deterioration and death.
    • Early signs include forgetfulness, difficulty finding words, problem-solving challenges, confusion, and disorientation.
    • The exact cause of Alzheimer’s is not fully understood but is believed to involve genetic, environmental, and lifestyle factors.
    • Family history, genetic mutations, head injuries, cardiovascular disease, and certain lifestyle factors are also risk factors.

    Donanemab: An antedote

    • Development: Donanemab is a drug developed by Eli Lilly and aims to treat individuals with early Alzheimer’s disease.
    • Targeting Amyloid Plaques: The drug targets a common hallmark of Alzheimer’s disease: amyloid plaques in the brain.

    Breakthrough in Slowing Cognitive Decline

    • Alarming Burden: With an estimated 14 million cases of dementia, including Alzheimer’s, expected in India by 2050, the need for effective treatments is urgent.
    • Phase III Trial: In a phase III trial, Donanemab demonstrated promising results, slowing cognitive decline by 35% compared to a placebo.
    • Significance: This marks a significant milestone in Alzheimer’s research, as it is the second drug, within a year, to show effectiveness in checking cognitive decline in early-stage Alzheimer’s patients.
    • Limitations: It is essential to note that Donanemab and the previous drug do not stop or reverse Alzheimer’s disease. However, slowing cognitive decline can significantly improve the quality of life for affected individuals and their families.

  • Bacteriophages: The Good Viruses that fight Bacteria

    bacteriophage

    Central Idea

    • Viruses have had a significant impact on human history, causing deadly outbreaks of diseases.
    • However, not all viruses are harmful, and scientists are discovering the importance of the virome (bacteriophages).

    Do you know?

    Viromes and bacteriophages are closely related because bacteriophages, or phages for short, are a type of virus that specifically infects bacteria.

    Bacteriophages are considered part of the virome, as they contribute to the overall viral genetic material present in a given environment or organism.

     

    What are Virome?

    • What is it: They are the collection of viruses in our bodies contributing to our health, similar to the bacterial microbiome.
    • Bacteriophages: The majority of viruses inside us are bacteriophages, which kill bacteria in our microbiomes without affecting human cells.
    • Vast in Numbers: Our bodies host around 380 trillion virus particles, 10x more than the number of bacteria.
    • Beneficial Viruses: Some viruses play beneficial roles, such as killing cancer cells, aiding immune system training, fighting pathogens, and regulating gene expression during pregnancy.

    Bacteriophages and Phage Therapy

    • Bacteriophages’ Mechanism: Bacteriophages hunt down bacteria, attach to their surface, inject viral DNA, and replicate inside the bacteria before causing the bacterial cell to burst and release new viral particles.
    • Historical Background: In the early 20th century, scientists explored phages as potential treatments for bacterial infections, but antibiotic development overshadowed this research.
    • Antibiotic Resistance: With the rise of antibiotic-resistant bacteria, scientists are revisiting phage therapy as an alternative to combat bacterial infections.
    • Advantages of Phages: Phages effectively target multi-resistant pathogens, are precise in eliminating bacterial strains, and do not disrupt the gut microbiome like antibiotics do.

    Phage Therapy in Practice

    • Historical Use: Phage therapy persisted in countries like Georgia, Ukraine, and Russia, where antibiotics were scarce. These regions have witnessed successful treatment outcomes against antibiotic-resistant infections.
    • Expanding Use: Phage therapy is gaining attention in countries like Belgium, the US, and Germany, with specialized therapy centres and calls for increased exploration and utilization.
    • Challenges and Safety: Standardization of therapy and tailoring phages to specific bacteria causing the infection remain challenges. However, phage therapies have a good safety record, and human bodies can tolerate them well.

    Future Prospects

    • Complementary Approach: Phages are unlikely to replace antibiotics but could be used in combination to enhance antibiotic effectiveness, particularly against resistant bacterial strains.
    • Research and Clinical Projects: Further large-scale research and clinical projects are recommended to establish effective phage therapies for different types of infections.

  • Crimean-Congo Haemorrhagic Fever (CCHF)

    cchf

    Central Idea

    • Europe is currently experiencing a heatwave and wildfires, leading to concerns about the spread of viruses that are typically not found in colder climates.
    • The WHO has issued an alert regarding the Crimean-Congo haemorrhagic fever (CCHF), a potentially fatal infection transmitted by ticks.

    What is CCHF?

    • CCHF is a viral haemorrhagic fever primarily transmitted by ticks.
    • It can also be contracted through contact with viraemic animal tissues during animal slaughter.
    • CCHF outbreaks can lead to epidemics with a high case-fatality ratio (10-40%) and pose challenges for prevention and treatment.

    Transmission and Hosts

    • The virus exists in the tick family of insects.
    • Animals such as cattle, goats, sheep, and hares serve as amplifying hosts for the virus.
    • Humans can contract CCHF through contact with infected ticks or animal blood.
    • The virus can also be transmitted between humans through contact with infectious blood or body fluids.
    • Migratory birds can host ticks, allowing the virus to spread over long distances.

    Symptoms and Treatment

    • Common symptoms of CCHF include fever, muscle aches, dizziness, neck and back pain, headache, sore eyes, and sensitivity to light.
    • Early symptoms may also include nausea, vomiting, diarrhea, abdominal pain, and sore throat, followed by mood swings and confusion.
    • Later stages may involve sleepiness, depression, and lassitude.
    • There is no vaccine available for CCHF in humans or animals, and treatment focuses on managing symptoms.
    • The antiviral drug ribavirin has been used to treat CCHF infection with some apparent benefit.

    Spread of CCHF in Europe

    • CCHF is endemic to Africa, the Balkan countries, the Middle East, and parts of Asia.
    • In 2016, Spain reported the first fatality from CCHF in Europe.
    • Scientists warn that CCHF, which can have a fatality rate between 10% and 40%, is spreading northward and westward in Europe.
    • Cases of CCHF have been reported in Spain, Russia, Turkey, and the UK.

    Reasons for this spread

    • Disrupted temperature patterns due to climate change are creating favorable conditions for pathogens.
    • CCHF ticks are moving northward through Europe due to longer and drier summers caused by climate change.
    • Climate change contributes to the spread of diseases by expanding tick habitats, altering water habitats, and facilitating the movement of animals and human interactions.